INNOVATIVE METHODS OF DIAGNOSIS AND TREATMENT IN WOMEN WITH INFERTILITY ASSOCIATED WITH UTERINE FIBROIDS

Abstract

The article presents innovative methods of diagnosis and treatment in women with infertility on the background of uterine
fibroids.
Target: To assess the role of uterine fibroids immunocorrection factors in the formation of clinical variants of uterine fibroids
to develop innovative methods of diagnosis and treatment in women with infertility against the background of reasonable
differentiated corrective therapy.
Materials and Methods: Survey 2018-2022 was conducted. in the Bukhara region, 175 questionnaires of women with
infectious and inflammatory diseases of the pelvic organs were analyzed. Of these, 140 (52.6%) had uterine fibroids of various
shapes and locations. Of these, single uterine fibroids occurred in 32% of cases, and 68% - multiple uterine fibroids. We
examined 85 women with clinical manifestations of uterine fibroids. 47 women with symptomatic uterine fibroids and
infertility and 38 with asymptomatic uterine fibroids and infertility.
Results: The results of the study showed that the complex treatment of women with symptomatic uterine fibroids and uterine
fibroids with the immunocorrective drug T-life after hormone therapy showed high efficiency, reproductive function was
restored in 64.3% of women, which without immunocorrection uterine myoma was 48.1%. in women with asymptomatic
uterine fibroids after hormone therapy, the inclusion of the drug Likopid had a positive clinical and immunocorrection effect
on uterine myoma, reproductive function was restored in 60.0% of women, which was 44.4% without uterine myoma
correction.